交银医药创新股票C(014046)
2025-01-27
2.0677
0.0629%
| 报告期 |
基金净值 |
股票 |
国债及现金 |
可转债 |
企业债 |
金融债 |
其他债券 |
其他投资 |
贷方余额 |
| 2024-12-31 | 220,304.47 | 185,568.41 | 35,775.05 | 0.00 | 0.00 | 0.00 | 0.00 | 1,649.04 | 0.00 |
| 2024-09-30 | 279,455.66 | 234,160.22 | 49,803.97 | 0.00 | 0.00 | 0.00 | 0.00 | 570.71 | 0.00 |
| 2024-06-30 | 278,525.99 | 230,810.77 | 47,757.68 | 0.00 | 0.00 | 0.00 | 0.00 | 1,083.01 | 0.00 |
| 2024-03-31 | 327,432.81 | 285,402.26 | 40,749.37 | 249.34 | 0.00 | 0.00 | 0.00 | 3,067.74 | 0.00 |
| 2023-12-31 | 387,549.29 | 343,228.86 | 47,189.84 | 0.00 | 0.00 | 0.00 | 0.00 | 423.92 | 0.00 |
| 2023-09-30 | 362,557.88 | 318,510.60 | 41,841.52 | 0.21 | 0.00 | 0.00 | 0.00 | 3,268.16 | 0.00 |
| 2023-06-30 | 372,983.86 | 320,603.99 | 50,769.99 | 0.22 | 0.00 | 0.00 | 0.00 | 4,704.36 | 0.00 |
| 2023-03-31 | 416,755.43 | 358,825.73 | 55,909.29 | 0.00 | 0.00 | 0.00 | 0.00 | 3,438.66 | 0.00 |
| 2022-12-31 | 369,027.02 | 323,142.31 | 47,077.27 | 0.00 | 0.00 | 0.00 | 0.00 | 1,531.42 | 0.00 |
| 2022-09-30 | 336,944.73 | 270,514.69 | 65,748.83 | 0.00 | 0.00 | 0.00 | 0.00 | 2,471.68 | 0.00 |
| 2022-06-30 | 420,405.04 | 351,249.14 | 73,370.14 | 0.13 | 0.00 | 0.00 | 0.00 | 1,344.31 | 0.00 |
| 2022-03-31 | 315,979.25 | 264,237.13 | 49,794.65 | 0.07 | 0.00 | 0.00 | 0.00 | 3,288.21 | 0.00 |
| 2021-12-31 | 391,592.37 | 345,308.47 | 46,921.35 | 31.44 | 0.00 | 0.00 | 0.00 | 1,018.97 | 0.00 |
